Category Archives: Hormone Replacement Therapy

A latest survey on Global Hormone Replacement Therapy (Hrt) Market is conducted to provide hidden gems performance analysis. Continue reading →

Samantha Howard launched a brutal kicking attack at three cops who went to her home in Hartlepool in April and caused damage to their patrol car. A month later, the 23-year-old sunk her teeth into an officer's arm after she was told to drop a knife she was carrying in the street outside her partner's home in Sunderland. Newcastle Crown Court heard at the time of the attacks, Howard was using "DIY hormone replacement" tablets bought online to help her transition from male to female Continue reading →

If youre a living, breathing human being, chances are you know someone impacted by Alzheimers disease. It is the sixth leading cause of death in the United States, killing more people than breast cancer and prostate cancer combined. Currently, more than five million Americans have Alzheimers disease, and that number is projected to grow to nearly 14 million by the year 2050. Continue reading →

ROCKLAND, Mass. and NEW YORK, June 30, 2020 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc Continue reading →

Several factors, including age, weight, genetics and environment, play a role in a woman's risk for breast cancer. Image Credit: Ridofranz/iStock/GettyImages Breast cancer is still the second most common cancer in women (after skin cancer), according to the American Cancer Society (ACS) Continue reading →

NEW YORK, July 1, 2020 /PRNewswire/ -- This report is 80% complete and can be delivered within three working days post order confirmation and will include the latest impact analysis of Covid-19 in 2020 and forecast. Read the full report: https://www.reportlinker.com/p05916725/?utm_source=PRN Global Autoimmune Disease Diagnostics Market By Type (Systemic, Organ-Specific), By Sex (Male, Female), By Age (0-15, 15-44, 44+), By Factors (Diet, Genetics, Environmental agents), By Diagnosis (Antinuclear Antibody Test, Autoantibody Test, Others), By Types of Treatment (Nonsteroidal Anti-Inflammatory Drugs, Immune-Suppressing Drugs, Others), By Product (Kits and assays, Reagents), By End-User (Hospital, Clinics, Others), By Region, Competition, Forecast & Opportunities, 2025 Global autoimmune disease diagnostics market size was valued at USD4 billion in 2019 and projected to grow at a formidable CAGR during the forecast period.The key factor driving the growth of autoimmune disease diagnostics market is surging investment in healthcare sector. Continue reading →

Global Seed Treatment Market 2020-2025 report draws precise insights by examining the latest and prospective industry trends and helping readers recognize the products and services that are boosting revenue growth and profitability. The Seed Treatment market study performs a detailed analysis of all the significant factors, including drivers, constraints, threats, challenges, prospects and industry-specific trends, impacting the market on a global and regional scale Continue reading →

A Cork woman who was told she would never be able to have children has given birth to a baby boy this week in a miraculous turn of events. Nuala OBrien believed she could never have children after suffering from cancer, which sent her into early menopause at age 25 due to ovarian failure. Continue reading →

Menopause starts 12 months after the last menstrual period or when menstruation has stopped because of a clinical reason, such as removal of the ovaries, and symptoms may include hot flashes, sleep disturbances, urinary problems, and vaginal dryness.1 In 2017, the North American Menopause Society updated its 2012 Hormone Therapy Position Statement based on new evidence of the benefits versus risks.2 The 2017 position statement discussed that hormone replacement therapy (HRT) provides the most benefit for women younger than 60 years within 10 years of menopause onset and no treatment contraindications.2 This patient population can be treated for vasomotor symptoms, such as hot flashes. Continue reading →

Includes positive clinical findings from a postcoital test (PCT) human clinical study of Ovaprene, an investigational hormone-free, monthly contraceptive SAN DIEGO, June 24, 2020 (GLOBE NEWSWIRE) -- DAR Bioscience, Inc. (NASDAQ: DARE), a leader in womens health innovation, today announced the publication of a literature review article by Biology of Reproduction that identifies and reviews 10 postcoital test (PCT) studies of vaginal contraceptives involving 9 test products, including Dars investigational hormone-free, monthly contraceptive Ovaprene, currently under a license agreement with Bayer for commercialization in the U.S. The literature review was conducted with the support and participation of the Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas, and Dar Bioscience Continue reading →